Elliot Keith Chartash

City:

Randolph, New Jersey

Country:

United States

Published Applications:

Last publication date:

2021-11-11

Top Assignees for applications by Elliot Keith Chartash

The entities that hold a legal rights for patent applications filed by inventor Chartash Elliot Keith:

ABBVIE BIOTECHNOLOGY LTD. 5 Hamilton, Bermuda
Abbott Laboratories 1 Abbott Park, IL United States
ABBVIE INC. 1 North Chicago, IL United States
Abbott Laboratories S.A. 1 Baar, Switzerland

Recent patent applications by Chartash Elliot Keith

Elliot Keith Chartash from Randolph, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2021-11-11

US20210347875A1

Chemistry; metallurgy

MULTIPLE-VARIABLE DOSE REGIMEN FOR TREATING TNFalpha-RELATED DISORDERS

#2 | 2019-02-21

US20190055308A1

Chemistry; metallurgy

MULTIPLE-VARIABLE DOSE REGIMEN FOR TREATING TNFalpha-RELATED DISORDERS

#3 | 2017-02-16

US20170044249A1

Chemistry; metallurgy

MULTIPLE-VARIABLE DOSE REGIMEN FOR TREATING TNFalpha-RELATED DISORDERS

#4 | 2014-09-11

US20140255396A1

Chemistry; metallurgy

Multiple-variable dose regimen for treating TNFα-related disorders

#5 | 2014-09-04

US20140248277A1

Chemistry; metallurgy

Multiple-variable dose regimen for treating TNFα-related disorders

#6 | 2014-09-04

US20140248276A1

Chemistry; metallurgy

MULTIPLE-VARIABLE DOSE REGIMEN FOR TREATING TNFALPHA-RELATED DISORDERS

#7 | 2014-09-04

US20140248275A1

Human necessities

MULTIPLE-VARIABLE DOSE REGIMEN FOR TREATING TNFALPHA-RELATED DISORDERS

#8 | 2014-07-31

US20140212430A1

Chemistry; metallurgy

MULTIPLE-VARIABLE DOSE REGIMEN FOR TREATING TNFALPHA-RELATED DISORDERS

#9 | 2010-11-25

US20100297143A1

Chemistry; metallurgy

Methods for treating psoriasis by administering an antibody which binds an epitope of the p40 subunit of IL-12 and/or IL-23

#10 | 2007-08-30

US20070202104A1

Chemistry; metallurgy

Treatment of spondyloarthropathies using TNFalpha inhibitors

InventorID:

853693 ⎘